Get the Stockscreener App
1.39
0.72%
0.01
After Hours:
1.40
0.01
+0.72%
Senti Biosciences Inc stock is traded at $1.39, with a volume of 187.22K.
It is up +0.72% in the last 24 hours and down -19.19% over the past month.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
See More
Previous Close:
$1.38
Open:
$1.36
24h Volume:
187.22K
Relative Volume:
0.63
Market Cap:
$36.36M
Revenue:
$1.79M
Net Income/Loss:
$-70.90M
P/E Ratio:
-0.0894
EPS:
-15.54
Net Cash Flow:
$-34.95M
1W Performance:
-5.44%
1M Performance:
-19.19%
6M Performance:
-56.15%
1Y Performance:
-52.88%
1-Day Range:
$1.32
$1.40
1-Week Range:
$1.32
$1.48
52-Week Range:
$1.32
$16.94
Senti Biosciences Inc Stock (SNTI) Company Profile
Name
Senti Biosciences Inc
Sector
Industry
Phone
(650) 239-2030
Address
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Compare SNTI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNTI
Senti Biosciences Inc
|
1.39 | 36.10M | 1.79M | -70.90M | -34.95M | -15.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-06-25 | Initiated | Laidlaw | Buy |
| Oct-07-22 | Initiated | Morgan Stanley | Equal-Weight |
Senti Biosciences Inc Stock (SNTI) Latest News
What technical models suggest about Senti Biosciences Inc.’s comeback2025 Analyst Calls & Real-Time Buy Zone Alerts - Newser
Will Senti Biosciences Inc. bounce back from current supportWeekly Stock Summary & Verified Entry Point Signals - Newser
Will Senti Biosciences Inc. benefit from macro trendsTrade Entry Report & Free Daily Entry Point Trade Alerts - Newser
Detecting price anomalies in Senti Biosciences Inc. with AIJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - Newser
Senti Biosciences Inc. stock daily chart insightsGlobal Markets & Free Reliable Trade Execution Plans - Newser
Order flow analysis tools used on Senti Biosciences Inc.2025 Institutional Moves & Weekly Breakout Watchlists - Newser
Is Senti Biosciences Inc. affected by consumer sentimentPortfolio Performance Report & Risk Managed Investment Signals - خودرو بانک
Does Senti Biosciences Inc. have declining or rising EPS2025 Performance Recap & Low Risk Growth Stock Ideas - خودرو بانک
How to use Fibonacci retracement on Senti Biosciences Inc.Weekly Stock Summary & AI Powered Market Entry Ideas - Newser
Sentiment analysis tools applied to Senti Biosciences Inc.Quarterly Portfolio Report & AI Forecast for Swing Trade Picks - Newser
How to escape a deep drawdown in Senti Biosciences Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
Will Senti Biosciences Inc. stock recover after recent dropSell Signal & AI Based Trade Execution Alerts - Newser
Can you recover from losses in Senti Biosciences Inc.2025 Short Interest & Accurate Technical Buy Alerts - Newser
Using economic indicators to assess Senti Biosciences Inc. potentialJuly 2025 Decliners & Verified Short-Term Plans - Newser
Is Senti Biosciences Inc. a cyclical or defensive stockJuly 2025 Movers & Low Risk High Win Rate Stock Picks - خودرو بانک
How to monitor Senti Biosciences Inc. with trend dashboardsWeekly Trading Summary & AI Enhanced Trading Signals - Newser
Will Senti Biosciences Inc. announce a stock splitJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Why Senti Biosciences Inc. is moving today2025 Key Lessons & Safe Investment Capital Preservation Plans - Newser
Can Senti Biosciences Inc. lead its sector in growthJuly 2025 Update & Free Safe Entry Trade Signal Reports - خودرو بانک
Senti Biosciences Inc. stock chart pattern explainedWall Street Watch & Fast Gaining Stock Strategy Reports - Newser
Aug Macro: What’s the fair value of Senti Biosciences Inc. stockLayoff News & Fast Moving Stock Trade Plans - خودرو بانک
Visualizing Senti Biosciences Inc. stock with heatmaps2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - Newser
Senti Biosciences Inc. stock momentum explainedTrade Volume Report & Verified Entry Point Signals - Newser
What momentum shifts mean for Senti Biosciences Inc.Trade Entry Summary & Advanced Swing Trade Entry Plans - Newser
How to integrate Senti Biosciences Inc. into portfolio analysis toolsGap Up & Community Verified Trade Signals - Newser
Predicting Senti Biosciences Inc. trend using moving averagesQuarterly Profit Summary & Fast Momentum Entry Tips - Newser
Is Senti Biosciences Inc. still worth holding after the dipWeekly Trend Summary & Community Supported Trade Ideas - Newser
What to do if you’re stuck in Senti Biosciences Inc.2025 Market Sentiment & Short-Term High Return Ideas - Newser
How does Senti Biosciences Inc. compare to its peers2025 Dividend Review & AI Forecasted Entry and Exit Points - خودرو بانک
Is Senti Biosciences Inc. a potential multi baggerWeekly Investment Summary & Free AI Powered Buy and Sell Recommendations - خودرو بانک
Senti Biosciences Inc. stock volume spike explainedQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - Newser
Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
Senti Biosciences to Present at H.C. Wainwright Global Investment Conference - AInvest
Risk Recap: Is Senti Biosciences Inc. forming bullish engulfing patternsJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - خودرو بانک
Is Senti Biosciences Inc. impacted by rising ratesWeekly Earnings Recap & Free AI Powered Buy and Sell Recommendations - خودرو بانک
Smart tools for monitoring Senti Biosciences Inc.’s price actionJuly 2025 Volume & Consistent Profit Trading Strategies - Newser
Senti Biosciences Inc Stock (SNTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Senti Biosciences Inc Stock (SNTI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lu Timothy K | CEO |
Feb 06 '25 |
Sale |
4.36 |
545 |
2,376 |
82,082 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 04 '25 |
Sale |
4.07 |
1,297 |
5,279 |
8,803 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. |
Feb 06 '25 |
Sale |
4.37 |
182 |
795 |
8,621 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):